Results
|
1.
|
|
|
2.
|
|
|
3.
|
|
|
4.
|
|
|
5.
|
|
|
6.
|
|
|
7.
|
|
|
8.
|
|
|
9.
|
|
|
10.
|
|
|
11.
|
|
|
12.
|
|
|
13.
|
|
|
14.
|
|
|
15.
|
Clinical outcomes of low and intermediate risk differentiated thyroid cancer patients treated with 30mCi for ablation or without radioactive iodine therapy. [electronic resource] by
- Súss, Shirlei Kugler Aiçar
- Mesa, Cleo Otaviano
- Carvalho, Gisah Amaral de
- Miasaki, Fabíola Yukiko
- Chaves, Carolina Perez
- Fuser, Dominique Cochat
- Corbo, Rossana
- Momesso, Denise
- Bulzico, Daniel A
- Graf, Hans
- Vaisman, Fernanda
Producer: 20180719
In:
Archives of endocrinology and metabolism vol. 62
Availability: No items available.
|
|
16.
|
Association of the UGT1A1-53(TA)n polymorphism with L-thyroxine doses required for thyrotropin suppression in patients with differentiated thyroid cancer. [electronic resource] by
- Vargens, Daniela D
- Neves, Ronaldo R S
- Bulzico, Daniel A
- Ojopi, Elida B
- Meirelles, Ricardo M R
- Pessoa, Cencita N
- Prado, Carolina M
- Gonçalves, Pedro A
- Leal, Vera L G
- Suarez-Kurtz, Guilherme
Producer: 20110818
In:
Pharmacogenetics and genomics vol. 21
Availability: No items available.
|
|
17.
|
Is there a role for epithelial-mesenchymal transition in adrenocortical tumors? [electronic resource] by
- Bulzico, Daniel
- Faria, Paulo Antônio Silvestre de
- Maia, Camila Bravo
- de Paula, Marcela Pessoa
- Torres, Davi Coe
- Ferreira, Gerson Moura
- Pires, Bruno Ricardo Barreto
- Hassan, Rocio
- Abdelhay, Eliana
- Vaisman, Mario
- Vieira Neto, Leonardo
Producer: 20180627
In:
Endocrine vol. 58
Availability: No items available.
|
|
18.
|
Is there a role for peptide receptor radionuclide therapy in medullary thyroid cancer? [electronic resource] by
- Vaisman, Fernanda
- Rosado de Castro, Paulo Henrique
- Lopes, Flavia Paiva Proença Lobo
- Kendler, Daniel Barretto
- Pessoa, Cencita H N
- Bulzico, Daniel Alves
- de Carvalho Leal, Douglas
- Vilhena, Bruno
- Vaisman, Mario
- Carneiro, Michel
- Corbo, Rossana
Producer: 20150831
In:
Clinical nuclear medicine vol. 40
Availability: No items available.
|
|
19.
|
Somatostatin receptor subtype 1 might be a predictor of better response to therapy in medullary thyroid carcinoma. [electronic resource] by
- Kendler, Daniel Barretto
- Araújo, Mario Lucio
- Alencar, Renata
- de Souza Accioly, Maria Theresa
- Bulzico, Daniel Alves
- de Noronha Pessoa, Cencita Cordeiro
- Accioly, Fernanda Andrade
- de Farias, Terence Pires
- Lopes, Flaia Paiva Proença Lobo
- Corbo, Rossana
- Vaisman, Mario
- Vaisman, Fernanda
Producer: 20180727
In:
Endocrine vol. 58
Availability: No items available.
|
|
20.
|
Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer. [electronic resource] by
- Santoro, Ana B
- Vargens, Daniela D
- Barros Filho, Mateus de Camargo
- Bulzico, Daniel A
- Kowalski, Luiz Paulo
- Meirelles, Ricardo M R
- Paula, Daniela P
- Neves, Ronaldo R S
- Pessoa, Cencita N
- Struchine, Claudio J
- Suarez-Kurtz, Guilherme
Producer: 20150729
In:
British journal of clinical pharmacology vol. 78
Availability: No items available.
|